First results of the Phase II TITAN trial: anti-von Willebrand ... - Ablynx
First results of the Phase II TITAN trial: anti-von Willebrand ... - Ablynx
First results of the Phase II TITAN trial: anti-von Willebrand ... - Ablynx
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
ALX-0081 potently neutralises ULVWF in vitro<br />
• Effective concentrations linked with VWF:Ag levels<br />
Ex vivo platelet string formation<br />
ULvWF<br />
ULvWF and <strong>anti</strong>-vWF Nanobody<br />
Anti-vWF Nanobody inhibits platelet string formation caused by<br />
ULvWF in plasma <strong>of</strong> TTP patients<br />
15